2025 年 6 月 16 日
“We continue to invest in the Phoenix platform to support the complex modeling needs of PK/PD scientists who rely on Phoenix for decision making,” said Martin Snyder, President, Data Science Software. “From the first non-compartmental analysis to safety assessment for millions of patients, Phoenix is a critical system throughout drug development.”
“Our Phoenix roadmap over the next year is groundbreaking,” said Snyder . “Our user community has asked for greater control to create, customize, and collaborate on the data visualizations that make up much of the Tables, Listings, and Figures section of submission documents. Later this year, they’ll have that ability with TFL Studio, the first module of the Phoenix Cloud.”
关于Certara
Certara 致力于通过生物模拟软件、技术和服务加速药物研发,改变传统的药物研发方式。其客户包括超 2,400 家生物制药公司、学术机构和来自 70 个国家的监管机构。Learn more at www.certara.com.
Certara 联系人:
Sheila Rocchio
[email protected]
媒体联系人:
Alyssa Horowitz
[email protected]